Home   Business   Article

Subscribe Now

CN Bio adds Human 24 to PhysioMimix to aid drug toxicity testing




CN Bio has launched its PhysioMimix DILI (drug-induced liver injury) assay kit: Human 24.

Based on Cambridge Science Park, CN Bio develops organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows.

The CN Bio team at their Cambridge Science Park base
The CN Bio team at their Cambridge Science Park base

Built on CN Bio’s human-derived and highly characterised liver microphysiological system (MPS), the DILI assay kit provides robust, human-relevant insights into crucial drug safety parameters, to support more informed clinical progression of drug candidates, enhanced clinical preparedness, and helps de-risk drug development workflows by ensuring only the most promising therapeutic candidates are selected.

Dr Ovidiu Novac, senior scientist and project manager (DILI assay kit), CN Bio, said: “Toxicology testing is perhaps the most essential part of developing a new drug.

“With Human 24, PhysioMimix users can now more easily replicate our industry-leading DILI assay in their own lab, providing deeper mechanistic insights into drug-induced hepatoxicity and enabling more confident progression of drug candidates into the clinic.”



Comments | 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More